Trial intelligence / Profile preview

PRF Functionalization of Prosthetic Patches for CDH

NCT03861182Phase 3Terminated

Sponsor
Strasbourg University Hospital
Start
Sep 2019
Primary completion
Dec 2019
Countries
1
01

Overview

Phase 3, open-label trial (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Comparison of cell colonization between neonate biomaterials and the same biomaterials functionalized by Platelet Rich Fibrin of healthy adult volunteers at 7 days. Started Sep 2019; status: terminated.

Beyond the preview

Go deeper on NCT03861182.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03861182.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call